AUPS317102A0 - Transdermal aerosol compositions - Google Patents
Transdermal aerosol compositionsInfo
- Publication number
- AUPS317102A0 AUPS317102A0 AUPS3171A AUPS317102A AUPS317102A0 AU PS317102 A0 AUPS317102 A0 AU PS317102A0 AU PS3171 A AUPS3171 A AU PS3171A AU PS317102 A AUPS317102 A AU PS317102A AU PS317102 A0 AUPS317102 A0 AU PS317102A0
- Authority
- AU
- Australia
- Prior art keywords
- aerosol compositions
- transdermal aerosol
- transdermal
- compositions
- aerosol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPS3171A AUPS317102A0 (en) | 2002-06-25 | 2002-06-25 | Transdermal aerosol compositions |
JP2004514437A JP2005533795A (en) | 2002-06-25 | 2003-06-24 | Transdermal aerosol composition |
EA200500082A EA007351B1 (en) | 2002-06-25 | 2003-06-24 | Pharmaceutical composition for transdermal delivery of physiologically active agents |
AU2003238543A AU2003238543B2 (en) | 2002-06-25 | 2003-06-24 | Transdermal aerosol compositions |
EP03732114A EP1534241A1 (en) | 2002-06-25 | 2003-06-24 | Transdermal aerosol compositions |
CA002490325A CA2490325A1 (en) | 2002-06-25 | 2003-06-24 | Transdermal aerosol compositions |
BR0312004-0A BR0312004A (en) | 2002-06-25 | 2003-06-24 | Transdermal Aerosol Compositions |
NZ537435A NZ537435A (en) | 2002-06-25 | 2003-06-24 | Transdermal aerosol compositions |
PCT/AU2003/000784 WO2004000275A1 (en) | 2002-06-25 | 2003-06-24 | Transdermal aerosol compositions |
KR1020047020967A KR20050071373A (en) | 2002-06-25 | 2003-06-24 | Transdermal aerosol compositions |
US11/019,121 US20050186141A1 (en) | 2002-06-25 | 2004-12-22 | Transdermal aerosol compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPS3171A AUPS317102A0 (en) | 2002-06-25 | 2002-06-25 | Transdermal aerosol compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPS317102A0 true AUPS317102A0 (en) | 2002-07-18 |
Family
ID=3836730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPS3171A Abandoned AUPS317102A0 (en) | 2002-06-25 | 2002-06-25 | Transdermal aerosol compositions |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1534241A1 (en) |
JP (1) | JP2005533795A (en) |
KR (1) | KR20050071373A (en) |
AU (1) | AUPS317102A0 (en) |
BR (1) | BR0312004A (en) |
CA (1) | CA2490325A1 (en) |
EA (1) | EA007351B1 (en) |
NZ (1) | NZ537435A (en) |
WO (1) | WO2004000275A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100055542A (en) * | 2002-06-25 | 2010-05-26 | 애크럭스 디디에스 피티와이 리미티드 | Transdermal delivery rate control using amorphous pharmaceutical compositions |
WO2005049026A1 (en) * | 2003-11-19 | 2005-06-02 | Acrux Dds Pty Ltd | Method and composition for treatment or prophylaxis of amyloidosis disorders |
US20060263421A1 (en) | 2005-05-18 | 2006-11-23 | Abeille Pharmaceuticals Inc | Transdermal Method and Patch for Nausea |
JP2011502172A (en) * | 2007-11-02 | 2011-01-20 | アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド | Transdermal delivery system for hormones and steroids |
ES2784627T3 (en) * | 2011-02-15 | 2020-09-29 | Audevard | Methods to control pain in horses using a fentanyl transdermal solution |
WO2012112348A1 (en) * | 2011-02-15 | 2012-08-23 | Eli Lilly And Company | Methods for controlling pain in canines using a transdermal solution of fentanyl |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
KR20220008824A (en) | 2019-04-17 | 2022-01-21 | 컴퍼스 패쓰파인더 리미티드 | How to treat anxiety disorders, headache disorders and eating disorders with psilocybin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5082866A (en) * | 1988-06-01 | 1992-01-21 | Odontex, Inc. | Biodegradable absorption enhancers |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US6004969A (en) * | 1996-04-15 | 1999-12-21 | National Science Council | Transdermal delivery of buprenorphine preparations |
ATE252380T1 (en) * | 1999-02-05 | 2003-11-15 | Cipla Ltd | TOPICAL SPRAYS CONTAINING A FILM-FORMING COMPOSITION |
IN191090B (en) * | 2000-08-29 | 2003-09-20 | Ranbanx Lab Ltd |
-
2002
- 2002-06-25 AU AUPS3171A patent/AUPS317102A0/en not_active Abandoned
-
2003
- 2003-06-24 BR BR0312004-0A patent/BR0312004A/en not_active IP Right Cessation
- 2003-06-24 KR KR1020047020967A patent/KR20050071373A/en active Search and Examination
- 2003-06-24 JP JP2004514437A patent/JP2005533795A/en not_active Withdrawn
- 2003-06-24 EP EP03732114A patent/EP1534241A1/en not_active Withdrawn
- 2003-06-24 WO PCT/AU2003/000784 patent/WO2004000275A1/en active Application Filing
- 2003-06-24 CA CA002490325A patent/CA2490325A1/en not_active Abandoned
- 2003-06-24 EA EA200500082A patent/EA007351B1/en not_active IP Right Cessation
- 2003-06-24 NZ NZ537435A patent/NZ537435A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR0312004A (en) | 2005-03-29 |
EP1534241A1 (en) | 2005-06-01 |
KR20050071373A (en) | 2005-07-07 |
WO2004000275A1 (en) | 2003-12-31 |
CA2490325A1 (en) | 2003-12-31 |
JP2005533795A (en) | 2005-11-10 |
EA200500082A1 (en) | 2005-06-30 |
EA007351B1 (en) | 2006-10-27 |
NZ537435A (en) | 2006-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003299034A1 (en) | Transdermal compositions | |
AU2003275719A1 (en) | Deodorant composition | |
AU2003254863A1 (en) | Herbicide compositions | |
AU2003262747A1 (en) | Compounds, compositions, and methods | |
AU2003236527A1 (en) | Compounds, compositions, and methods | |
AU2003265242A1 (en) | Compounds, compositions, and methods | |
AU2003285288A1 (en) | Composition | |
AU2003291103A1 (en) | Pharmaceutical composition | |
AU2003270015A1 (en) | Compounds, compositions, and methods | |
AU2003288133A1 (en) | Herbidical composition | |
AU2003299612A1 (en) | Compounds, compositions and methods | |
AU2003256805A1 (en) | Compounds compositions and methods | |
AU2003250372A1 (en) | Pharmaceutical composition | |
AU2003218121A1 (en) | Lotion compositions | |
AU2002950744A0 (en) | Composition | |
AU2002362187A1 (en) | Spraying composition | |
AU2003236353A1 (en) | Photopolymerizable composition | |
AU2003276710A1 (en) | Deodorant composition | |
AU2003235708A1 (en) | Polytartrate composition | |
AU2003226487A1 (en) | Formulation | |
EP1400571A3 (en) | Aerosol composition | |
AU2003290507A1 (en) | Compounds, compositions and methods | |
AU2003277079A1 (en) | Compounds, compositions, and methods | |
AU2003269904A1 (en) | Antigen-polymer compositions | |
AU2003208411A1 (en) | Anti-glycolytic composition |